Immunologic Studies of Antithrombin III Heparin Cofactor in the Newborn

Summary

Serial quantitative immunoelectrophoretic (IE) measurements of antithrombin III heparin cofactor (AT III) were made in groups of well and sick newborn infants classified by gestational age. Collection methods (venous vs. capillary) did not influence the results; serum IE measurements were comparable to AT III activity by a clotting method. AT III is gestational age-dependent, increasing from 28.7% of normal adult values at 28-32 weeks to 50.9% at 37-40 weeks, and shows a gradual increase to term infant levels (57.4%) by 3-4 weeks of age. Infants with the respiratory distress syndrome (RDS) show lower levels of AT III in the 33-36 week group, 22% vs. 44% and in the 37-40 week group, 33.6% vs. 50.9%, than prematures without RDS. Infants of 28-32 week gestational age had only slight differences, RDS = 24%, non-RDS = 28.7%. The lowest levels of AT III were seen in patients with RDS complicated by disseminated intravascular coagulation and those with necrotizing enterocolitis. Crossed IE on representative infants displayed a consistent pattern which was identical to adult controls except for appropriate decreases in the amplitude of the peaks. The thrombotic complications seen in the sick preterm infant may be related to the low levels of AT III.

• References

• 1 Abildgaard U, Fagerhol MK, Egeberg O. 1970; Comparison of progressive antithrombin activity and the concentrations of three thrombin inhibitors in human plasma. Scandinavian Journal Clinical and Laboratory Investigation 26: 349
• 2 Alstatt LB, Dennis LH, Sundell H, Malan A, Harrison V, Hedvall G, Eichelberger J, Fogel B, Stahlman M. 1971; Disseminated intravascular coagulation and hyaline membrane diseage. Biology of the Neonate 19: 227
• 3 Egeberg O. 1965; Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 13: 516
• 4 Hutter Jr JJ, Hathaway WE, Wayne ER. 1967; Hematologic abnormalities in severe neonatal necrotizing enterocolitis. Journal of Pediatrics 88: 1026
• 5 Laurell CB. 1972; Electroimmunoassay. Scandinavian Journal Clinical and Laboratory Investigation 29 Suppl (Suppl. 124) 21
• 6 Mahasandana C, Hathaway WE. 1973; Circulating anticoagulants in the newborn: relation to hypercoagulability and the idiopathic respiratory distress syndrome. Pediatric Research 7: 670
• 7 Marciniak E, Farley CH, Desimone PA. 1974; Familial thrombosis due to antithrombin III deficiency. Blood 43: 219
• 8 Markarian M, Lubchenco LO, Rosenblit E, Fernandez F, Land D, Jackson JJ, Bannon AE, Lindley A, Githens JH, Mortorell R. 1971; Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. II. The effect of heparin. Biology of the Neonate 17: 98
• 9 Rosenberg RD. 1977; Chemistry of the hemostatic mechanism and its relationship to the action of heparin. Federation Proceedings 36: 10
• 10 Sas G, Pepper FS, Cash JD. 1975; Plasma and serum antithrombin III : differentiation by crossed Immunoelectrophoresis. Thrombosis Research 6: 87
• 11 Singer AD, Thiebeault DW, Hobel CJ, Heiner DC. 1977; Serum plasminogen and lung surfactant in the respiratory distress syndrome. Pediatric Research 11: 119
• 12 Teger-NILSSON AC. 1975; Antithrombin in infancy and childhood. Acta Pediatrica Scandinavica 64: 624
• 13 Weissbach G, Domula M, Lenk H, Schneider P. 1974; The progressive antithrombin activity and its relations to other factors of the coagulation system in newborns. Acta Paediatrica Scandinavica 67: 555